This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

| Real-world evidence lets us see how HIV medicines work in real life, helping HCPs provide better care and improving ...

LEN is a first-in-class, long-acting HIV-1 capsid inhibitor that disrupts multiple stages of the viral replication cycle. By ...

One of the hot topics at this year's Conference on Retroviruses and Opportunistic Infections will be long COVID: potential ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

By Albert Allotey Accra, GNA-The JANOK Foundation, a non-governmental organization at Laterbiokorshie in Accra has ...

HIV-positive mothers with undetectable viral load can now safely breastfeed their infants, according to recently updated ...

The Association of Government Information Officers in Region 8 (AGIO-8), led by its president, lawyer Jonalyndie B. Chua ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Researchers from the Max Planck Institute of Biochemistry have discovered the mechanism behind an important step in the life ...

These viruses encode a reverse transcriptase enzyme that converts the RNA genome into DNA during the retroviral life cycle, which then ... of the Gag protein of HIV-1 is induced by the proteolytic ...